Search company, investor...

Founded Year

2005

Stage

Unattributed VC | Alive

Total Raised

$47M

Last Raised

$2M | 16 yrs ago

About Alinea Pharmaceuticals

Alinea Pharmaceuticals, Inc. offers pharmaceuticals for diabetes and related metabolic disorders

Headquarters Location

One Memorial Drive Suite 1225

Cambridge, Massachusetts, 02142,

United States

617-633-5659

Loading...

Loading...

Alinea Pharmaceuticals Patents

Alinea Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/8/2010

4/24/2012

Diabetes, EC 1.1.1, Cell biology, Human proteins, Membrane biology

Grant

Application Date

2/8/2010

Grant Date

4/24/2012

Title

Related Topics

Diabetes, EC 1.1.1, Cell biology, Human proteins, Membrane biology

Status

Grant

Alinea Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Alinea Pharmaceuticals founded?

    Alinea Pharmaceuticals was founded in 2005.

  • Where is Alinea Pharmaceuticals's headquarters?

    Alinea Pharmaceuticals's headquarters is located at One Memorial Drive, Cambridge.

  • What is Alinea Pharmaceuticals's latest funding round?

    Alinea Pharmaceuticals's latest funding round is Unattributed VC.

  • How much did Alinea Pharmaceuticals raise?

    Alinea Pharmaceuticals raised a total of $47M.

  • Who are the investors of Alinea Pharmaceuticals?

    Investors of Alinea Pharmaceuticals include MPM Capital, Flagship Pioneering, Burrill & Company and SV Health Investors.

  • Who are Alinea Pharmaceuticals's competitors?

    Competitors of Alinea Pharmaceuticals include Diasome, Adastra Pharmaceuticals, Azevan Pharmaceuticals, Amylin Pharmaceuticals, ISTA Pharmaceuticals and 7 more.

Loading...

Compare Alinea Pharmaceuticals to Competitors

D
Diasome

Diasome operates as a clinical-stage biopharmaceutical company that focuses on hepatocyte cell targeting to treat metabolic diseases. The company's main offerings include therapies that restore hepatocyte metabolism, addressing common metabolic disorders such as diabetes, obesity, and dyslipidemia. These therapies leverage the natural regulatory functions of hepatocytes. It was founded in 2004 and is based in Cleveland, Ohio.

A
Ausio Pharmaceuticals

Ausio Pharmaceuticals is a clinical-stage biotechnology development company focused on creating safe and effective medicines within the pharmaceutical industry. The company's main product, AUS-131, is a nonsteroidal, nonhormonal estrogen receptor β (ERβ) agonist designed to address conditions such as menopausal symptoms, benign prostatic hyperplasia, Alzheimer’s disease, and triple negative breast cancer. Ausio Pharmaceuticals aims to collaborate with partners to bring AUS-131 to markets in the United States and internationally. It is based in Cincinnati, Ohio.

B
Bluefish Pharmaceuticals

Bluefish Pharmaceuticals is a progressive company in the pharmaceutical industry with a focus on generic drug products. The company specializes in the development and manufacturing of quality generic medications accessible to a broader population. Bluefish Pharmaceuticals primarily serves the healthcare sector by providing affordable pharmaceutical options. It is based in Sweden.

G
Greystone Pharmaceuticals

Greystone Pharmaceuticals focuses on the development of wound care technologies within the pharmaceutical industry. The company offers a range of products designed to improve the quality of life for individuals with chronic wounds. These products are aimed at reducing healthcare costs while providing effective wound care solutions. It was founded in 1996 and is based in Fort Myers, Florida.

I
Intarcia Therapeutics

Intarcia Therapeutics operates as a biopharmaceutical company. The company develops and commercializes therapies to transform the prevention and management of chronic diseases. The company was founded in 1995 and is based in Boston, Massachusetts.

V
Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.